| Report ID | 279806 |
| Drug Identification Number | 02370069 |
| Brand name | BENLYSTA |
| Common or Proper name | belimumab lyophilized powder for intravenous infusion |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BELIMUMAB |
| Strength(s) | 400MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1x20mL |
| ATC code | L04AG |
| ATC description | |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2026-03-20 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-03-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-05 | French | Compare |
| v1 | 2026-03-05 | English | Compare |
Showing 1 to 2 of 2